Corrigendum to “Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway” [Int. Immunopharmacol. 177 (2026) 116526]
Corrigendum to “Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway” [Int. Immunopharmacol. 177 (2026) 116526] is a paper indexed in PICO Portal from OpenAlex.
How many citations does Corrigendum to “Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway” [Int. Immunopharmacol. 177 (2026) 116526] have?
Corrigendum to “Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway” [Int. Immunopharmacol. 177 (2026) 116526] has 0 citations in the OpenAlex counts PICO Portal stores.
When was Corrigendum to “Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway” [Int. Immunopharmacol. 177 (2026) 116526] published?
Corrigendum to “Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway” [Int. Immunopharmacol. 177 (2026) 116526] has 2026 year in the PICO Portal index.
What is the open-access status of Corrigendum to “Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway” [Int. Immunopharmacol. 177 (2026) 116526]?
Corrigendum to “Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway” [Int. Immunopharmacol. 177 (2026) 116526] has closed oa status in the PICO Portal index.
What is the DOI of Corrigendum to “Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway” [Int. Immunopharmacol. 177 (2026) 116526]?
The DOI for Corrigendum to “Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway” [Int. Immunopharmacol. 177 (2026) 116526] is on the source record.
What is the PMID of Corrigendum to “Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway” [Int. Immunopharmacol. 177 (2026) 116526]?
The PMID for Corrigendum to “Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway” [Int. Immunopharmacol. 177 (2026) 116526] is on the source record.
What is the OpenAlex record for Corrigendum to “Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway” [Int. Immunopharmacol. 177 (2026) 116526]?
The OpenAlex for Corrigendum to “Tetrahydrocoptisine alleviates postoperative delirium with sleep disturbances by modulating the TH/NLRP3 Inflammasome pathway” [Int. Immunopharmacol. 177 (2026) 116526] is on the source record.